Isoeugenodilol: A vasorelaxant α/β-adrenoceptor blocker with antioxidant activity

Drug Development Research

Volumn 51, Issue 1, 2000, Pages 29-42

  Yeh, Jwu Lai ^a   Yang, Tzu Hsin ^a   Liang, Jhy Chong ^a   Huang, Yeun Chih ^a   Lo, Yi Ching ^a   Wu, Jiunn Ren ^a   Lin, Young Tso ^a   Chen, Ing Jun ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

adrenoceptor blockade; Antioxidant activity; Isoeugenol; Vasorelaxant effect

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIOXIDANT; BETA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL; CALCIUM ION; GLIBENCLAMIDE; ISOEUGENODILOL; ISOPRENALINE; LABETALOL; NORADRENALIN; PHENYLEPHRINE; POTASSIUM CHANNEL; POTASSIUM ION; PRAZOSIN; PROPRANOLOL; TETRYLAMMONIUM; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CALCIUM MOBILIZATION; CHRONOTROPISM; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG ACTIVITY; FEMALE; HYPERTENSION; INOTROPISM; LIPID PEROXIDATION; MALE; NONHUMAN; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TACHYCARDIA; THORACIC AORTA; VASODILATATION;

EID: 0033752827     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2299(20000901)51:1<29::AID-DDR4>3.0.CO;2-2     Document Type: Article

References (40)

1. Some quantitative uses of drug antagonist
2. Free radical scavenging and inhibition of lipid peroxidation by β-blockers and by agents that interfere with calcium metabolism
3. The assessment of β-adrenoceptor blocking potency and cardioselectivity in vitro and in vivo
4. Inositol triphosphate and calcium signalling
5. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding
6. Novel 21-aminosteroids as potent inhibitors of iron-dependent lipid peroxidation
7. Xanthonolol: A calcium channel and β-adrenoceptor blocker with vasodilating properties
8. Guaiacoxypropanolamine derivatives of capsaicin: A new family of β-adrenoceptor blockers with intrinsic cardiotonic properties
9. Capsinolol: The first β-adrenoceptor blocker with an associated calcitonin gene-related peptide releasing activity in the heart
10. 2-agonist and calcium mobilization inhibition associated vasorelaxant activities
11. The vasorelaxant effect of evodiamine in rat isolated mesenteric arteries
12. The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory
13. Negative inotropic effects and the hydrophobicity of beta-adrenergic blocking agents
14. 2-adrenoceptor agonist-associated vasorelaxant activities
15. 2-agonist activity
16. Calcium channels in smooth muscle
17. Stimulant and depressant effects of β-adrenoceptor blocking agents on isolated heart muscle: A positive inotropic effects not mediated through adrenoceptors
18. Cytosolic-free calcium transients in cultured vascular smooth muscle cells: Microfluorometric measurements
19. Labedipinedilol-A: A vanilloid-based α/β-adrenoceptor blocker with calcium entry blocking and long acting anti-hypertensive properties
20. 1-adrenoceptor antagonist
21. 1-adrenoceptor antagonist with tracheal and vascular smooth nmscle relaxant properties
22. Inhibition of sacrolemmal carbon-centered free radical formation by propranolol
23. Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents
24. 2+
25. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone
26. Activation of a single alpha-1-adrenoceptor subtype in rat aorta mobilizes intracellular and extracellular pools of calcium
27. β-Blockade in heart failure: Basic concepts and clinical results
28. Dihydrozingerone and isoeugenol as inhibitors of lipid peroxidation and as free radical scavengers
29. Eugenol and prostaglandin biosynthesis
30. Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist
31. The attraction of protein for small molecules and ions
32. Vanidilol: A vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity
33. Myosin phosphorylation in smooth and skeletal muscles: Regulation and function
34. 1-adrenoceptor blocking agent
35. Zingeronolol: A newly developed β-adrenoceptor blocking agent derived from zingerone, a pungent principle of ginger
36. 2-agonist activity derived from ferulic acid, an active component of Ligusticum wallichii Franch
37. Inhibitory properties of NIP-21, a potassium channel opener, on high potassium- and norepinephrine-induced contraction and calcium mobilization in rat aorta
38. Vanidipinedilol: A vanilloid-based β-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities
39. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger